ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
val-zoledronic acid solution
bausch health, canada inc. - acide zolédronique (acide zolédronique hémipentahydraté) - solution - 4mg - acide zolédronique (acide zolédronique hémipentahydraté) 4mg - bone resorption inhibitors
prolastin-c poudre pour solution
grifols therapeutics llc - inhibiteur de l'alpha1-protéinase (humain) - poudre pour solution - 1000mg - inhibiteur de l'alpha1-protéinase (humain) 1000mg - enzymes
prolastin-c liquid solution
grifols therapeutics llc - inhibiteur de l'alpha1-protéinase (humain) - solution - 1000mg - inhibiteur de l'alpha1-protéinase (humain) 1000mg - enzymes
inflectra poudre pour solution
celltrion healthcare co ltd - infliximab - poudre pour solution - 100mg - infliximab 100mg - disease-modifying antirheumatic agents
ixifi poudre pour solution
pfizer canada ulc - infliximab - poudre pour solution - 100mg - infliximab 100mg
remsima poudre pour solution
celltrion healthcare co ltd - infliximab - poudre pour solution - 100mg - infliximab 100mg - disease-modifying antirheumatic agents
renflexis poudre pour solution
samsung bioepis co., ltd - infliximab - poudre pour solution - 100mg - infliximab 100mg - disease-modifying antirheumatic agents
glassia solution
takeda canada inc - inhibiteur de l'alpha1-protéinase (humain) - solution - 1000mg - inhibiteur de l'alpha1-protéinase (humain) 1000mg - enzymes
mitoxantrone injection usp solution
pfizer canada ulc - mitoxantrone (chlorhydrate de mitoxantrone) - solution - 2mg - mitoxantrone (chlorhydrate de mitoxantrone) 2mg - antineoplastic agents